Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| First Affiliated Hospital of Zhejiang University | OTHER |
| Shulan (Hangzhou) Hospital | OTHER |
| The Affiliated Hospital of Qingdao University | OTHER |
Not provided
Not provided
Not provided
Not provided
CT imaging-based skeletal muscle assessment has been found to predict the outcomes of many diseases. Previous evidence revealed that pre-transplant muscle quality and post-transplant muscle loss were associated with transplant outcomes. However, there is no prospective study supporting the aforementioned conclusions. This study aims to prospectively include liver transplant patients from multiple transplant centers, collecting their pre-transplant CT images as well as post-transplant CT images at specific time points. The objective is to further explore and clarify the correlation between skeletal muscle assessment and the prognosis of liver transplant patients. The goal is to provide guidance for peri-transplant health monitoring and disease intervention for liver transplant patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Myosteatotic Group | The group of patients was diagnosed with myosteatosis through CT imaging assessment before transplantation. | ||
| Non-myosteatotic Group | The group of patients was diagnosed without myosteatosis through CT imaging assessment before transplantation. | ||
| The Group with Severe Muscle Loss | The group of patients, through the comparison of CT images before and after transplantation, was diagnosed with significant muscle loss. | ||
| The Group without Severe Muscle Loss | The group of patients, through the comparison of CT images before and after transplantation, was diagnosed without significant muscle loss. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative mortality | 2024.1.1-2027.1.1 | |
| Postoperative recurrence of liver cancer | Specifically for the included patients who undergo liver transplantation for liver cancer | 2024.1.1-2027.1.1 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Liver transplant patients from multiple transplant centers in China
Not provided
| ID | Term |
|---|---|
| D009133 | Muscular Atrophy |
| ID | Term |
|---|---|
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D001284 | Atrophy |
Not provided
Not provided
| West China Hospital |
| OTHER |
| Huashan Hospital | OTHER |
Not provided
Not provided
Not provided
| D020763 |
| Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |